German Government Plans Corona Vaccine Contracts Until End of Decade
Germany’s governing cabinet has drawn up contracts with five companies to deliver anti-coronavirus vaccines until 2029. The companies in question are BioNTech, Curevac/GSK, Wacker/CordenPharma, Celonic and IDT.
The Ministry for Economic Affairs and Climate Action negotiated the prospective “pandemic preparedness contracts” at the behest of the Ministry of Health.
“We’ve learned our lessons from the coronavirus pandemic and the initial scarcity of vaccines,” said Economics Minister Robert Habeck. “With these contracts, we will secure the production and supply of vaccines for the coming years and protect people in Germany.”
The German government estimates that it will spend almost EUR 2.9 billion on corona vaccinations between 2022 and 2029. The contracts aim to ensure the continuation of production capacities that were new created in the fight against the disease.
“This is significant news for vaccine developers and manufacturers,” says Germany Trade & Invest Director of Chemicals and Health Marcus Schmidt. “The measure should prevent a boom and bust scenario and strengthen Germany’s leading role in this industry.”